Industry News
Feature: Targeting leukaemia
Australian-US pharmaceutical company, ChemGenex, is close to bringing a new targeted drug to market, with implications for chronic myelogenous leukaemia and other blood-borne cancers. [ + ]
Product Wars: Survival gadgets
If the Tom Hanks movie Cast Away is anything to go by, being marooned on a deserted island is not much fun. [ + ]
NCRIS rolls out upgraded biotech labs
UNSW and Macquarie open upgraded labs for CV, cancer and biofuels research. [ + ]
Feature: Untying the haplomics knot
Unravelling the haplotype could reveal heretofore unknown links between genes and diseases. Dr Malcolm Simons thinks he might have a solution to this epic challenge. [ + ]
Gene therapy cures colour blindness
Adult monkeys colour blind since birth given trichromatic vision. [ + ]
Australian scientist launches authorship management system
A Brisbane-based researcher has launched an effective authorship management system that promises to reduce conflict for researchers during their careers.
[ + ]UNSW conjures geneticist as new Dean of Science
Merlin Crossley to take Dean's chair at the University of New South Wales in January 2010. [ + ]
IVD Australia launches
IVD Australia is a recently formed association that represents companies that manufacture and supply in-vitro diagnostics in Australia.
[ + ]Feature: Blooming controversy
Traditional notions of biological classification based on morphology are being shaken up by the new practice of molecular taxonomy. But far from being contradictory approaches, they may end up being complementary. [ + ]
Feature: Genetic headache
What does the mutiny on the Bounty have to do with the genetics of migraine? Lyn Griffiths talks about her voyage to Norfolk Island, the last home of the Bounty mutineers, to find out what they can teach us about migraine. [ + ]
200 mid-career researchers awarded Future Fellowships
Two hundred outstanding national and international mid-career researchers have been awarded ARC Future Fellowships in an attempt to address the gap in opportunities for mid-career researchers in Australia.
[ + ]ChemGenex targets NDA for OMAPRO
New drug application for targeted anti-leukaemia drug completed, mid-2010 launch expected. [ + ]
Toolkit gives new life to medical research philanthropy
Help is at hand for medical researchers looking for philanthropic support to deliver health benefits to the community.
[ + ]Y chromosome may not be a dysfunctional loner after all
X and Y chromosomes have been shown to exchange DNA, refuting the scientific theory that the two chromosomes do not communicate at all.
[ + ]